Anti-amyloid Alzheimer’s drugs fail to demonstrate significant clinical benefits
Recent comprehensive analysis has cast significant doubt on the clinical value of drugs targeting amyloid beta proteins in the brains ...
Recent comprehensive analysis has cast significant doubt on the clinical value of drugs targeting amyloid beta proteins in the brains ...
In a groundbreaking study published in Nature Chemical Biology, researchers have unveiled the critical role of tau phosphorylation in the ...
A groundbreaking study published in Nature Communications has shed new light on the human brain's glymphatic system, revealing its crucial ...
In a groundbreaking study published in Nature Communications, researchers have unveiled compelling evidence that the glymphatic system plays a pivotal ...
Research into the mechanisms behind Alzheimer’s disease (AD) has garnered increasing attention as the global population ages and the burden ...
In a groundbreaking study authored by Bergo et al., the increasing urgency to address Alzheimer’s disease has catalyzed innovative approaches ...
In a groundbreaking new study published in Nature Neuroscience, researchers have uncovered a complex interplay between microglia and astrocytes that ...
In a groundbreaking new study, researchers have unveiled the intricate molecular interplay that governs microglial phagocytosis within the context of ...
Tauopathies represent a challenging frontier in neurodegenerative disease research, primarily due to their hallmark pathological feature: the aggregation of tau ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine